Table 3.

Percentage of women with cytologic abnormalities stratified by age

Type/groupNTotal *Overall % abnormal cytologiesNABN+% Abnormal within age group (y) NASC§% ASC within age group (y) NLSIL% LSIL within age group (y)NHSIL+% HSIL or worse within age group (y)
<3535-54>54<3535-54>54<3535-54>54<3535-54>54
All single infections1,22224.830326.828.313.913443.146.242.49737.926.524.27219.027.433.3
α1/α8/α10/α137218.11318.521.411.8980.050.0100.0420.050.00.00
α9/α1136234.312433.741.721.23630.926.727.33332.422.29.15536.851.163.6
α9/α11 (HPV16−)20631.16433.930.920.02334.241.233.32239.029.416.71926.829.450.0
α721825.75624.830.120.02950.054.650.02146.231.825.063.913.625.0
α5/α620330.56233.732.417.72740.650.033.32753.133.333.386.316.733.3
α3/α1536713.14815.615.36.33368.275.050.01227.315.050.034.610.00.0
All carcinogenic57034.419634.839.621.06634.335.123.56640.027.023.56425.737.852.9
HPV1615638.56033.352.822.71325.917.920.01122.217.90.03651.964.380.0
Carcinogenic (HPV16−)41432.913635.334.320.35337.245.725.05546.232.633.32816.721.741.7
Noncarcinogenic65216.410717.918.910.26862.565.162.53133.325.625.084.29.312.5
  • Abbreviation: ABN+, abnormal cytologies; ASC, atypical squamous cells; LSIL, low-grade intraepithelial lesions; HSIL+, high-grade intraepithelial lesions or worse.

  • * Total frequency of women.

  • Frequency of women with cytologic abnormalities or ASC or worse cytologies.

  • Percentage of women within each age group with abnormal or ASC or worse cytologies. There were 153, 117, and 33 abnormal women in the <35, 35–54, and >54 year-old age groups, respectively.

  • § Frequency of women with ASC cytologies.

  • Percentage of similarly aged women with cytologic abnormalities that have ASC cytologies.